When NASAs Juno space mission arrived at Jupiter in 2016, we caught a glimpse of the remarkable beauty of the biggest planet in our Solar System
Long-term risks unknown: Chronic use could have consequences that have not yet been documented
Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T, Mukaida N
Daily intraperitoneal administration for 11 days reduced body weight gain, decreased white adipose tissue mass by approximately 35%, and reduced adipocyte size, while food intake between treated and control groups did not differ significantly
The goal is finding the minimum effective dose, not automatically climbing to the maximum
F.VignesM.GuiramandJ